Government of Canada improves access to affordable and effective drugs for rare diseases

In Canada, one out of twelve people—many of whom are children—has a rare disease. Unfortunately, treatments are only available for a small percentage of these conditions. Even when treatments that might dramatically improve the quality of a patient's life are available, they are often unaffordable and out of reach.

Today, the Honourable Jean-Yves Duclos, Minister of Health, announced measures in support of the first-ever National Strategy for Drugs for Rare Diseases, with an investment of up to $1.5 billion over three years. Through this, we will help increase access to, and affordability of, effective drugs for rare diseases to improve the health of patients across Canada, including children.

Government of Canada announces agreement with leading COVID-19 vaccine developer Moderna, Inc. to build mRNA vaccine facility in Canada

MONTRÉAL, Aug. 10, 2021 /CNW/ - Today, the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced a major milestone in Canada's strategy to rebuild the biomanufacturing and life sciences sector. The Government of Canada has established a memorandum of understanding (MOU) with leading COVID-19 vaccine developer Moderna, Inc. to build a state-of-the-art mRNA vaccine production facility in Canada.

NewsCatherine LamontagneAugust 10, 2021Government of Canada, Moderna, Vaccines

Government of Canada announces major steps in treating and preventing COVID-19 through vaccines and therapies

NewsGuest UserAugust 7, 2020Government of Canada

Canada and the United Kingdom collaborate on responsible artificial intelligence

Canada is a global leader in artificial intelligence (AI)—the single-largest transformative technology in the world. Fostering Canada’s advantage in digital technologies, including AI, is one of the pillars of the Government of Canada’s economic growth strategy.